NCI Will Participate in RFA-HG-11-003, "Development of a Preliminary Evidence Base to Inform Decision-making about Returning Research Results to Participants in Genomic Studies (R01)"
Release Date: January 3, 2011
National Cancer Institute (NCI)
This Notice is to inform potential applicants that the National Cancer Institute (NCI) will participate in Request for Application (RFA) RFA-HG-11-003, entitled “Development of a Preliminary Evidence Base to Inform Decision-making about Returning Research Results to Participants in Genomic Studies (R01)," effective immediately.
of Federal Domestic Assistance Number:
The Components of Participating Organizations section of RFA-HG-11-003 has been revised to include NCI:
Components of Participating Organizations
All other aspects of this Funding Opportunity Announcement remain the same.
direct all inquiries to:
Sheri Schully, Ph.D.
Epidemiology and Genetics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
6130 Executive Boulevard, EPN Room 5124, MSC 7393
Bethesda, MD 20892-7393 (for U.S. Postal Service express or regular mail)
Rockville, MD 20852 (for non-U.S.P.S. delivery)
Telephone: (301) 435-4911
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)